[Federal Register Volume 70, Number 57 (Friday, March 25, 2005)]
[Notices]
[Pages 15296-15297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-5922]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of a U.S. Government-Owned 
Patent

AGENCY: Department of the army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209 and 37 CFR 404.7(a)(1)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license within the geographic area of the United 
States of America and its territories and possessions to U.S. 
Provisional Patent S.N. 60/533,375, filed April 13, 2004 entitled 
``Marburg Virus-Like Particles as a Vaccine for Prevention of Lethal 
Marburg Virus Disease,'' U.S. Patent application 10/289,839, filed 
November 7, 2002 entitled ``Generation of Virus-like Particles and 
Demonstration of Lipid Rafts as Sites of Filovirus Entry and Budding,'' 
and U.S. Patent application 10/066,506, filed January 31, 2002 
entitled, ``Chimeric Filovirus Glycoprotein,'' for the specific claims 
and use related to the virus-like particle technology described 
therein, to be limited to the field of use of developing and 
commercializing prophylactic (preventative) vaccines and 
immunotherapties (active and passive) against the Ebola and Marburg 
filoviruses, individually or jointly to Virionics Corporation with its 
principal place of business at 19108 Barksdale Court, Germantown, MD 
20874-1526.

[[Page 15297]]


ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, within 15 days from the date of this publication. 
Written objections are to be filed with the Command Judge Advocate, 
U.S. Army Medical Research and Materiel Command, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 05-5922 Filed 3-24-05; 8:45 am]
BILLING CODE 3710-08-M